{"id":104735,"date":"2024-09-19T16:12:00","date_gmt":"2024-09-19T14:12:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=104735"},"modified":"2024-09-19T13:27:12","modified_gmt":"2024-09-19T11:27:12","slug":"cptx-financing","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/","title":{"rendered":"CPTx raises 26 million euros"},"content":{"rendered":"<div class=\"entry-content\">\n<p>The financing round, with a total volume of approximately \u20ac26 million ($29 million), was led by Blueyard Capital and Sprind. Bayern Kapital, Marius Nacht Group, Andrej Henkler, and several industry-experienced business angels also invested in CPTx. The startup plans to invest the funds in the further development of its antiviral platform technology and in expanding its team.<\/p>\n\n\n\n<p>CPTx, short for Composite Programmable Therapeutics, was founded in 2021 as a spin-off of the Technical University of Munich. <a href=\"\/en\/day\/biotech\/\">Biotech<\/a>-Company develops a new <a href=\"https:\/\/www.cptx.bio\/technology\" target=\"_blank\" rel=\"noreferrer noopener\">Platform technology<\/a>, which combines so-called DNA nanofabrication with synthetic biology. This will enable the creation of customized objects in scalable quantities that can perform various functions in drug development. In this process, a target object is designed and its 3D shape and functionality are encoded into DNA strands. These strands are then manufactured chemically or biotechnologically and assembled through thermal annealing. Combined with other functions, the CPTx platform is intended to offer new possibilities for antiviral therapeutics, gene transfer, and vaccine development.<\/p>\n\n\n\n<p><strong>Hendrik Dietz<\/strong>, CEO and founder of CPTx, comments on the financing:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&quot;We are very pleased that a consortium of industry-experienced investors has recognized the immense potential of our platform technology. This enables us to complete the preclinical development phase and explore further fields of application.&quot;<\/p>\n<\/blockquote>\n\n\n\n<p>And <strong>Monika Steger<\/strong>, Managing Director of Bayern Kapital, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&quot;Given our experiences with the COVID pandemic, but also with the annual flu epidemics, we know how important it is to have options for treating viral diseases. CPTx is the result of years of intensive research, some of which have made new possibilities such as the use of DNA nanofabrication on a scalable, cost-effective scale possible. The team&#039;s academic and entrepreneurial expertise is immense, and this current funding is another example of how Bayern Kapital supports innovative spin-off projects from Bavarian universities based on outstanding technologies, even in their early stages. We see great potential for CPTx to become a leading company in the field of nanotechnology.&quot;<\/p>\n<\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The biotech startup CPTx has closed a \u20ac26 million ($29 million) funding round. CPTx, a spin-off from the Technical University of Munich, is working on a new type of programmable therapeutics designed to facilitate the treatment of complex diseases.<\/p>","protected":false},"author":42,"featured_media":104769,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[371,5200,52],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CPTx sammelt 26 Millionen Euro ein - Munich Startup<\/title>\n<meta name=\"description\" content=\"CPTx hat eine Finanzierung von 26 Millionen Euro abgeschlossen. Das Biotech arbeitet an programmierbaren Therapeutika zur Behandlung komplexer Erkrankungen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CPTx sammelt 26 Millionen Euro ein - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"CPTx hat eine Finanzierung von 26 Millionen Euro abgeschlossen. Das Biotech arbeitet an programmierbaren Therapeutika zur Behandlung komplexer Erkrankungen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-19T14:12:00+00:00\" \/>\n<meta name=\"author\" content=\"Saskia Doll\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saskia Doll\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/\",\"name\":\"CPTx sammelt 26 Millionen Euro ein - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg\",\"datePublished\":\"2024-09-19T14:12:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\"},\"description\":\"CPTx hat eine Finanzierung von 26 Millionen Euro abgeschlossen. Das Biotech arbeitet an programmierbaren Therapeutika zur Behandlung komplexer Erkrankungen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg\",\"width\":2400,\"height\":1350,\"caption\":\"CPTx\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CPTx sammelt 26 Millionen Euro ein\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\",\"name\":\"Saskia Doll\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"caption\":\"Saskia Doll\"},\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/doll\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CPTx raises 26 million euros - Munich Startup","description":"CPTx has closed a \u20ac26 million financing round. The biotech company is working on programmable therapeutics for the treatment of complex diseases.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/","og_locale":"en_US","og_type":"article","og_title":"CPTx sammelt 26 Millionen Euro ein - Munich Startup","og_description":"CPTx hat eine Finanzierung von 26 Millionen Euro abgeschlossen. Das Biotech arbeitet an programmierbaren Therapeutika zur Behandlung komplexer Erkrankungen.","og_url":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2024-09-19T14:12:00+00:00","author":"Saskia Doll","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Saskia Doll","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/","url":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/","name":"CPTx raises 26 million euros - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg","datePublished":"2024-09-19T14:12:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5"},"description":"CPTx has closed a \u20ac26 million financing round. The biotech company is working on programmable therapeutics for the treatment of complex diseases.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg","width":2400,"height":1350,"caption":"CPTx"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/en\/104735\/cptx-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"CPTx sammelt 26 Millionen Euro ein"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5","name":"Saskia Doll","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","caption":"Saskia Doll"},"url":"https:\/\/cms.munich-startup.net\/en\/author\/doll\/"}]},"og_image":[{"width":2400,"height":1350,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/09\/CPTx_Grafik_Eingekapselter-Virus_5.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1726745233:42","_edit_last":"42","_yoast_wpseo_focuskw":"CPTx","_yoast_wpseo_metadesc":"CPTx hat eine Finanzierung von 26 Millionen Euro abgeschlossen. Das Biotech arbeitet an programmierbaren Therapeutika zur Behandlung komplexer Erkrankungen.","_yoast_wpseo_linkdex":"68","_thumbnail_id":"104769","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"90","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/104735"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=104735"}],"version-history":[{"count":2,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/104735\/revisions"}],"predecessor-version":[{"id":104737,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/104735\/revisions\/104737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/104769"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=104735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=104735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=104735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}